BrainZell

BrainZell’s human brain organoid assays help pharma companies create new medicines for brain disorders by effective prediction of drug outcomes, increasing the success rate of clinical trials. There is no cure for dementia, and treatments for mental illnesses have severe side effects. BrainZell develops human cell-based brain models that improve success rates of clinical trials. The technology helps pharmaceutical companies develop safe and effective medicines.